pomalidomide has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, S; Cooper, A; Denton, CP; Distler, JHW; Domsic, RT; Furst, DE; Horan, G; Hough, DR; Hsu, VM; Korish, S; Rischmueller, M; Schafer, PH; Stanislav, M; Steen, VD | 1 |
| Saketkoo, LA | 1 |
1 trial(s) available for pomalidomide and Sclerosis, Systemic
| Article | Year |
|---|---|
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
Topics: Adult; Double-Blind Method; Early Termination of Clinical Trials; Female; Fibrosis; Follow-Up Studies; Forced Expiratory Volume; Humans; Immunologic Factors; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Scleroderma, Systemic; Skin; Thalidomide; Treatment Outcome; Vital Capacity | 2018 |
1 other study(ies) available for pomalidomide and Sclerosis, Systemic
| Article | Year |
|---|---|
Successful Trial Design and Planning in Systemic Sclerosis: Does It Take a Village?
Topics: Delivery of Health Care; Double-Blind Method; Humans; Lung Diseases, Interstitial; Scleroderma, Systemic; Thalidomide | 2018 |